MedPath

Preventing Perinatal Depression

Not Applicable
Completed
Conditions
Perinatal Depression
Registration Number
NCT06525922
Lead Sponsor
Oregon Health and Science University
Brief Summary

The goal of this pilot study is to evaluate the acceptability, feasibility, mechanisms of action, and efficacy of Center M. Center M is a group-based, mindfulness-based Cognitive Behavioral Therapy (CBT) intervention to treat Perinatal Depression (PD).

Detailed Description

The goal of this pilot study is to evaluate the acceptability, feasibility, mechanisms of action, and efficacy of Center M. Center M is a group-based, mindfulness-based Cognitive Behavioral Therapy (CBT) intervention to treat Perinatal Depression (PD). Pregnant participants will be surveyed at three time points: pre-intervention, post-intervention, and 6-weeks postpartum. Surveys will include self-report measures evaluating depressive symptoms, mindfulness skills, emotion regulation, and participant satisfaction.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
87
Inclusion Criteria
  • gestational age at intervention onset between 12 and 30 weeks
  • English fluency
  • no previous experience in a mindfulness-based intervention group
  • ability and willingness to participate in a telehealth intervention
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Edinburgh Postnatal Depression Scale (EPDS)Measured at pre-intervention (within 1 week before first session), post-intervention (within 1 week after last session), and 6-weeks postpartum

10-item self-report measure used to assess perinatal depression symptomology over the past seven days.

Emotional Regulation Questionnaire (ERQ)Measured at pre-intervention (within 1 week before first session) and 6-weeks postpartum

10-item self-report measure used to assess one's ability to regulate or manage emotion using cognitive reappraisal and expressive suppression.

Five Facets of Mindfulness Questionnaire (FFMQ)Measured at pre-intervention (within 1 week before first session) and 6-weeks postpartum

39-item self-report measure to assess mindfulness skills.

Patient Health Questionnaire - 8 (PHQ-8)Measured at pre-intervention (within 1 week before first session), post-intervention (within 1 week after last session), and 6-weeks postpartum

Self-report measure that assesses depressive symptoms over the past two weeks.

Secondary Outcome Measures
NameTimeMethod
ERQ Cognitive Reappraisal SubscaleMeasured at pre-intervention (within 1 week before first session) and 6-weeks postpartum

6 items to reflect cognitive reframing or restructuring.

ERQ Expressive Suppression SubscaleMeasured at pre-intervention (within 1 week before first session) and 6-weeks postpartum

4 items to reflect expressive suppression.

Center M SatisfactionPost-intervention (within 1 week after last session)

60 minute telehealth format focus groups including open-ended questions about their experience with Center M or two-question survey with a Likert scale satisfaction question and a free text question.

Trial Locations

Locations (1)

Oregon Health & Science University

🇺🇸

Portland, Oregon, United States

Oregon Health & Science University
🇺🇸Portland, Oregon, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.